DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 937 filers reported holding DANAHER CORPORATION in Q4 2014. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $440,476,740 | +2.5% | 1,775,400 | -0.8% | 3.82% | +6.9% |
Q2 2023 | $429,672,000 | -4.7% | 1,790,300 | +0.1% | 3.58% | -9.8% |
Q1 2023 | $450,697,928 | -5.0% | 1,788,200 | 0.0% | 3.97% | -7.6% |
Q4 2022 | $474,624,044 | +11.0% | 1,788,200 | +8.0% | 4.29% | +13.7% |
Q3 2022 | $427,547,000 | +1.9% | 1,655,300 | 0.0% | 3.77% | +12.3% |
Q2 2022 | $419,652,000 | -13.6% | 1,655,300 | 0.0% | 3.36% | +1.4% |
Q1 2022 | $485,549,000 | -10.8% | 1,655,300 | 0.0% | 3.31% | +9.0% |
Q4 2021 | $544,610,000 | +8.1% | 1,655,300 | 0.0% | 3.04% | -2.1% |
Q3 2021 | $503,940,000 | +13.4% | 1,655,300 | 0.0% | 3.10% | +13.4% |
Q2 2021 | $444,216,000 | +19.2% | 1,655,300 | 0.0% | 2.74% | +7.8% |
Q1 2021 | $372,575,000 | +1.3% | 1,655,300 | 0.0% | 2.54% | +2.1% |
Q4 2020 | $367,708,000 | +3.2% | 1,655,300 | 0.0% | 2.48% | -1.1% |
Q3 2020 | $356,436,000 | +21.8% | 1,655,300 | 0.0% | 2.51% | +14.0% |
Q2 2020 | $292,707,000 | +27.8% | 1,655,300 | 0.0% | 2.20% | -0.9% |
Q1 2020 | $229,110,000 | -9.8% | 1,655,300 | 0.0% | 2.23% | -4.5% |
Q4 2019 | $254,055,000 | +6.3% | 1,655,300 | 0.0% | 2.33% | -1.1% |
Q3 2019 | $239,075,000 | +1.1% | 1,655,300 | 0.0% | 2.36% | -1.8% |
Q2 2019 | $236,575,000 | +8.3% | 1,655,300 | 0.0% | 2.40% | +4.0% |
Q1 2019 | $218,533,000 | +28.0% | 1,655,300 | 0.0% | 2.31% | +6.7% |
Q4 2018 | $170,695,000 | -5.1% | 1,655,300 | 0.0% | 2.16% | +2.9% |
Q3 2018 | $179,865,000 | +10.1% | 1,655,300 | 0.0% | 2.10% | +1.7% |
Q2 2018 | $163,345,000 | +0.8% | 1,655,300 | 0.0% | 2.06% | -3.0% |
Q1 2018 | $162,070,000 | +5.5% | 1,655,300 | 0.0% | 2.13% | +0.0% |
Q4 2017 | $153,645,000 | +8.2% | 1,655,300 | 0.0% | 2.13% | +2.5% |
Q3 2017 | $141,992,000 | +1.6% | 1,655,300 | 0.0% | 2.08% | -8.6% |
Q2 2017 | $139,691,000 | -1.3% | 1,655,300 | 0.0% | 2.27% | -2.4% |
Q1 2017 | $141,578,000 | -45.1% | 1,655,300 | -50.0% | 2.33% | -1.5% |
Q4 2016 | $257,698,000 | +119.2% | 3,310,600 | +120.7% | 2.36% | +4.7% |
Q3 2016 | $117,585,000 | -22.4% | 1,500,000 | 0.0% | 2.26% | -26.1% |
Q2 2016 | $151,500,000 | +6.5% | 1,500,000 | 0.0% | 3.05% | +1.9% |
Q1 2016 | $142,290,000 | +2.1% | 1,500,000 | 0.0% | 3.00% | -3.1% |
Q4 2015 | $139,320,000 | +9.0% | 1,500,000 | 0.0% | 3.09% | +4.3% |
Q3 2015 | $127,815,000 | -0.4% | 1,500,000 | 0.0% | 2.96% | -4.1% |
Q2 2015 | $128,385,000 | +0.8% | 1,500,000 | 0.0% | 3.09% | -4.3% |
Q1 2015 | $127,350,000 | -0.9% | 1,500,000 | 0.0% | 3.23% | -4.6% |
Q4 2014 | $128,565,000 | -10.9% | 1,500,000 | -21.1% | 3.38% | -17.3% |
Q3 2014 | $144,362,000 | +22.2% | 1,900,000 | +26.7% | 4.10% | +19.4% |
Q2 2014 | $118,095,000 | +424.9% | 1,500,000 | +400.0% | 3.43% | +376.5% |
Q1 2014 | $22,500,000 | +4.1% | 300,000 | +7.1% | 0.72% | -10.0% |
Q4 2013 | $21,616,000 | – | 280,000 | – | 0.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |